⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ERNA News
Ernexa Therapeutics Inc. Common Stock
Form 8-K
sec.gov
ERNA
ERNAW
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
globenewswire.com
ERNA
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
globenewswire.com
ERNA
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
globenewswire.com
ERNA
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
globenewswire.com
ERNA
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer
globenewswire.com
ERNA
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer
globenewswire.com
ERNA
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting
globenewswire.com
ERNA
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG
globenewswire.com
ERNA
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
globenewswire.com
ERNA